Innate Pharma SA (0EVI) Revenue

0 Followers

Innate Pharma SA Revenue

Innate Pharma SA had a revenue of 3.12M in the quarter ending Jun 30, 2026, with 250.27%. This bring the company's revenue in the last twelve months to 1.04M, Increased -62.61%. In the fiscal year ending Dec 31, 2025, Innate Pharma SA had annual revenue of 2.79M with -77.92% growth.

Revenue (ttm)

1.04M

Revenue Growth

-29.48%

P/S Ratio

52.74

Revenue/Employee

€17,098

Employees

163

Market Cap

€147.00M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	2.79M	-9.84M	-77.92%
Dec 31, 2024	12.62M	-39.28M	-75.68%
Dec 31, 2023	51.90M	2.26M	+4.56%
Dec 31, 2022	49.64M	37.53M	+309.83%
Dec 31, 2021	12.11M	-57.66M	-82.64%
Dec 31, 2020	69.77M	800.00K	+1.16%
Dec 31, 2019	68.97M	-10.92M	-13.67%
Dec 31, 2018	79.89M	47.26M	+144.83%
Dec 31, 2017	32.63M	―	―